JMP Securities Boosts Target on Threshold Pharmaceuticals (THLD), Sees 72% Upside
Tweet
Share
E-mailGet Alerts THLD Hot Sheet
Price: $0.54 --0%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 4
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 4
Join SI Premium – FREE
JMP Securities lifted its price target on Market Outperform-rated Threshold Pharmaceuticals (NASDAQ: THLD) from $7 to $12. The new price target represents 72% upside to Friday's close.
For an analyst ratings summary and ratings history on Threshold Pharmaceuticals click here. For more ratings news on Threshold Pharmaceuticals click here.
Shares of Threshold Pharmaceuticals closed at $6.99 yesterday.
For an analyst ratings summary and ratings history on Threshold Pharmaceuticals click here. For more ratings news on Threshold Pharmaceuticals click here.
Shares of Threshold Pharmaceuticals closed at $6.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MaxLinear (MXL) PT Raised to $120 at Stifel
- Boyd Gaming (BYD) PT Raised to $92 at Stifel Following Quarter With No Surprises
- Mobileye N.V (MBLY) PT Lowered to $9 at UBS as Stock Expected to Be Range-Bound
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
